Natalie R. Fitzgerald

Cost-effectiveness of Lung Cancer Screening in Canada

John R. Goffin, W. Michael Flanagan, Anthony B. Miller et al. · JAMA Oncology · 2015 · 121 citations · Full text

Medicine, Oncology, Preventive Medicine +17

Biennial lung cancer screening in Canada with smoking cessation—outcomes and cost-effectiveness

John R. Goffin, W. Michael Flanagan, Anthony B. Miller et al. · Lung Cancer · 2016 · 65 citations

Medicine, Oncology, Preventive Medicine +14

The OncoSim Model: Development and Use for Better Decision-Making in Canadian Cancer Control

Cindy L. Gauvreau, Natalie R. Fitzgerald, S. Memon et al. · Current Oncology · 2017 · 45 citations · Full text

Public Health, Biostatistics, Oncology +17

Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model

William K. Evans, Cindy L. Gauvreau, W. Michael Flanagan et al. · CMAJ Open · 2020 · 35 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

Performance of the cancer risk management model lung cancer screening module.

W. Michael Flanagan, William K. Evans, Natalie R. Fitzgerald et al. · PubMed · 2015 · 21 citations

Medicine, Biostatistics, Preventive Medicine +17